peposertib
1 product
2 abstracts
1 target
Abstract
Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma.Org: The University of Texas MD Anderson Cancer Center, Department of Neuro-Oncology, Department of Biostatistics & Data Science, Department of Radiation Oncology, University of California Irvine,
Abstract
ETCTN 10366: A phase 1 study of DNA-PK inhibitor peposertib in combination with hypofractionated radiotherapy for the treatment of locally advanced pancreatic adenocarcinoma.Org: NewYork-Presbyterian/Weill Cornell Medical Center,